𝔖 Bobbio Scriptorium

✦ LIBER ✦

215 POSTER HER2/Neu-Herceptin biomarker development for theranostic management of breast cancer patients

✍ Scribed by E. Luther; A. Glazyrin; W. Geddie; J. Eliason

Book ID: 118623843
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 53 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70220-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2129 POSTER An open-label study of capec

2129 POSTER An open-label study of capecitabine (C) and docetaxel (D) as neoadjuvant treatment for patients with recently diagnosed HER2-neu negative (HER2–) breast cancer (BC) plus trastuzumab (T) for HER2-neu positive (HER2+) BC

✍ D. Tripathy; C. Moisa; S. Glück 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB